DrugPatentWatch Database Preview
Drugs in Development Information for OTO-104
Try a free trial
See Plans and Pricing
Summary for OTO-104
| US Patents | 2,558 |
| International Patents | 43,330 |
| US Patent Applications | 4,526 |
| WIPO Patent Applications | 2,770 |
| Japanese Patent Applications | 20 |
| Clinical Trial Progress | Phase 3 (2013-11-01) |
| Vendors | 68 |
US Patents for OTO-104
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| OTO-104 | ➤ Sign Up | 11-substituted bile acid derivatives, process for the preparation thereof and use of these compounds as medicaments | Council of Scientific and Industrial Research (New Delhi, IN) | ➤ Sign Up |
| OTO-104 | ➤ Sign Up | Low, immune enhancing, dose mtor inhibitors and uses thereof | Novartis AG (Basel, CH) | ➤ Sign Up |
| OTO-104 | ➤ Sign Up | Therapeutic compounds and methods of use thereof | GENENTECH, INC. (South San Francisco, CA) XENON PHARMACEUTICALS INC. (Burnaby, BC, CA) | ➤ Sign Up |
| OTO-104 | ➤ Sign Up | Substituted indole Mcl-1 inhibitors | Vanderbilt University (Nashville, TN) | ➤ Sign Up |
| OTO-104 | ➤ Sign Up | Pharmaceutical compounds | Cascadian Therapeutics, Inc. (Seattle, WA) | ➤ Sign Up |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for OTO-104
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| OTO-104 | World Intellectual Property Organization (WIPO) | 2015087340 | 1989-12-31 | ➤ Sign Up |
| OTO-104 | Australia | 2014348657 | 2033-11-13 | ➤ Sign Up |
| OTO-104 | Australia | 2017245411 | 2033-11-13 | ➤ Sign Up |
| OTO-104 | Canada | 2929181 | 2033-11-13 | ➤ Sign Up |
| OTO-104 | China | 105899232 | 2033-11-13 | ➤ Sign Up |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
